Halozyme Therapeutics | Nettoeinkommen



Net Income Veränderung Datum
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amarin USD -25134000 26.66M 2024-09
Amgen USD 627M 2.2B 2024-12
Baxter International USD -512000000 652M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
DBV Technologies USD -30442000 2.67M 2024-09
Eli Lilly USD 4.41B 3.44B 2024-12
Halozyme Therapeutics USD 137.01M 1000 2024-12
Indivior 4M 111M 2024-09
Intra Cellular Therapies USD -16885000 9.44M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
MannKind USD 7.42M 4.13M 2024-12
Pfizer USD 410M 4.06B 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12



Halozyme Therapeutics Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.